8-K Announcements
6Material company update
May 22, 2026·SEC
Material company update
Apr 16, 2026·SEC
Material company update
Dec 18, 2025·SEC
Cosmos Health Inc.(COSM)Earnings, Financials & Key Ratios
COSM•NASDAQ
Price updated Jun 19, 2026
AboutCosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.Show more
- Revenue$65M+19.9%
- EBITDA-$15M-6.1%
- Net Income-$19M-18.3%
- EPS (Diluted)-0.63+46.2%
- Gross Margin12.1%+52.7%
- EBITDA Margin-23.24%+11.5%
- Operating Margin-25.34%+11.3%
- Net Margin-29.33%+1.4%
- ROE-89.13%-66.8%
COSM Key Insights
Cosmos Health Inc. (COSM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.3x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 5 (bottom 5%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 58.2% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when COSM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
COSM Price & Volume
Cosmos Health Inc. (COSM) stock price & volume — 10-year historical chart
Loading chart...
COSM Growth Metrics
Cosmos Health Inc. (COSM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years61.71%
5 Years3.33%
3 Years9.04%
TTM29.75%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-39.63%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM41.99%
Return on Capital
10 Years-23.77%
5 Years-41.43%
3 Years-51.07%
Last Year-59.33%
COSM Recent Earnings
Cosmos Health Inc. (COSM) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (56%)●Beat Revenue 4/12 qtrs (44%)
Q2 2026Latest
May 20, 2026Metric
Actual
Est
EPS
$0.33-725.0%
$0.04
Rev
$20M+4.7%
$19M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.17-1600.0%
$0.01
Rev
$17M+4.3%
$16M
Q3 2025
Aug 18, 2025Metric
Actual
Est
EPS
$0.06-700.0%
$0.01
Rev
$15M-15.6%
$17M
Q2 2025
May 15, 2025Metric
Actual
Est
EPS
$0.01+133.3%
$0.03
Rev
$14M-11.5%
$16M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 20, 2026 | $0.33vs $0.04-725.0% | $20Mvs $19M+4.7% |
| Q4 2025 | Nov 14, 2025 | $0.17vs $0.01-1600.0% | $17Mvs $16M+4.3% |
| Q3 2025 | Aug 18, 2025 | $0.06vs $0.01-700.0% | $15Mvs $17M-15.6% |
| Q2 2025 | May 15, 2025 | $0.01vs $0.03+133.3% | $14Mvs $16M-11.5% |
Based on last 12 quarters of dataView full earnings history →
COSM Peer Comparison
Cosmos Health Inc. (COSM) competitors in Consumer health and OTC self-care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HROW | 1.6B | 42.87 | -306.21 | 36.41% | -5.57% | -33.92% | 4.84 | |
 NTRB | 35.86M | 2.95 | -1.14 | -4.83% | -448.39% | -112.6% | 0.03 | |
 XTLB | 279.46K | 2.54 | -0.26 | -227.72% | -25.53% | 0.03 | ||
 CODA | 112.81M | 10.00 | 27.03 | 30.75% | 17.66% | 8.33% | 0.01 | |
 PHVS | 2.15B | 32.80 | -9.60 | -67.38% | 0.00 | |||
 PAHC | 1.29B | 31.85 | 26.76 | 27.37% | 6.29% | 30.81% | 2.67 | |
 PRGO | 1.42B | 10.25 | -1.00 | -2.75% | -43.5% | -50.65% | 1.35 | |
 AMRX | 5.1B | 16.21 | 73.68 | 8.05% | 2.39% | 7.47% | 0.13 |
Compare COSM vs Peers
Cosmos Health Inc. (COSM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
COSM Income Statement
Cosmos Health Inc. (COSM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 30.01M | 37.08M | 39.68M | 55.41M | 56.24M | 50.35M | 53.38M | 54.43M | 65.27M | 69.49M |
Revenue Growth % | 344.28% | 23.56% | 6.99% | 39.65% | 1.5% | -10.48% | 6.02% | 1.97% | 19.93% | 29.75% |
Cost of Goods Sold | 28.06M | 34.68M | 36.01M | 47.35M | 47.91M | 44.39M | 49.03M | 50.12M | 57.38M | 62.26M |
COGS % of Revenue | 93.48% | 93.5% | 90.77% | 85.45% | 85.19% | 88.17% | 91.85% | 92.08% | 87.9% | - |
Gross Profit | 1.96M▲ 0% | 2.41M▲ 23.1% | 3.66M▲ 52.0% | 8.06M▲ 120.1% | 8.33M▲ 3.4% | 5.96M▼ 28.5% | 4.35M▼ 27.0% | 4.31M▼ 0.9% | 7.9M▲ 83.1% | 7.23M▲ 0% |
Gross Margin % | 6.52% | 6.5% | 9.23% | 14.55% | 14.81% | 11.83% | 8.15% | 7.92% | 12.1% | 10.4% |
Gross Profit Growth % | 225.48% | 23.12% | 52.05% | 120.09% | 3.35% | -28.49% | -26.98% | -0.88% | 83.14% | - |
Operating Expenses | 6.83M | 3.64M | 3.92M | 5.35M | 12.86M | 13.43M | 26.18M | 19.86M | 24.44M | 25.12M |
OpEx % of Revenue | 22.75% | 9.81% | 9.88% | 9.65% | 22.87% | 26.68% | 49.05% | 36.48% | 37.44% | - |
Selling, General & Admin | 4.85M | 3.59M | 3.52M | 4.95M | 12.41M | 13.24M | 25.57M | 12.09M | 22.55M | 19.9M |
SG&A % of Revenue | 16.17% | 9.69% | 8.88% | 8.93% | 22.07% | 26.3% | 47.9% | 22.21% | 34.54% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 533.29K | 519.36K | 503.73K |
R&D % of Revenue | - | - | - | - | - | - | - | 0.98% | 0.8% | - |
Other Operating Expenses | 1.98M | 43.93K | 394.63K | 397.6K | 449.69K | 188.89K | 614.38K | 7.23M | 1.37M | 2.67M |
Operating Income | -4.87M▲ 0% | -1.23M▲ 74.8% | -255.81K▲ 79.2% | 2.71M▲ 1161.1% | -4.53M▼ 267.0% | -7.47M▼ 64.9% | -21.83M▼ 192.1% | -15.54M▲ 28.8% | -16.54M▼ 6.4% | -17.89M▲ 0% |
Operating Margin % | -16.23% | -3.31% | -0.64% | 4.9% | -8.06% | -14.84% | -40.9% | -28.56% | -25.34% | -25.75% |
Operating Income Growth % | -2306% | 74.79% | 79.18% | 1161.06% | -267.02% | -64.87% | -192.09% | 28.8% | -6.41% | - |
EBITDA | -4.85M | -1.18M | 138.82K | 3.11M | -4.08M | -7.29M | -21.22M | -14.3M | -15.17M | -16.49M |
EBITDA Margin % | -16.15% | -3.19% | 0.35% | 5.62% | -7.26% | -14.47% | -39.75% | -26.27% | -23.24% | -23.74% |
EBITDA Growth % | -2410.33% | 75.56% | 111.72% | 2141.69% | -231.23% | -78.4% | -191.23% | 32.62% | -6.13% | -24.1% |
D&A (Non-Cash Add-back) | 25.9K | 43.93K | 394.63K | 397.6K | 449.69K | 188.89K | 614.38K | 1.25M | 1.37M | 1.4M |
EBIT | -4.57M | -2.24M | -1.38M | 3.99M | -4.27M | -9.09M | -17.68M | -15.17M | -16.52M | -18.28M |
Net Interest Income | -1.64M | -6.81M | -1.73M | -2.73M | -3.53M | -3.73M | -203.62K | -605.87K | -2.23M | -2.7M |
Interest Income | 0 | 0 | 0 | 65.86K | 46.32K | 236.35K | 662.86K | 406.45K | 396.41K | 351.76K |
Interest Expense | 1.64M | 6.81M | 1.73M | 2.8M | 3.58M | 3.97M | 866.48K | 1.01M | 2.62M | 3.05M |
Other Income/Expense | -1.33M | -7.81M | -2.86M | -1.52M | -3.31M | -5.58M | 3.29M | -638.19K | -2.6M | -3.24M |
Pretax Income | -6.21M▲ 0% | -9.04M▼ 45.7% | -3.12M▲ 65.5% | 1.2M▲ 138.5% | -7.85M▼ 754.9% | -13.06M▼ 66.4% | -18.54M▼ 42.0% | -16.18M▲ 12.7% | -19.14M▼ 18.3% | -21.13M▲ 0% |
Pretax Margin % | -20.68% | -24.39% | -7.85% | 2.16% | -13.95% | -25.93% | -34.74% | -29.73% | -29.33% | -30.41% |
Income Tax | 2.8K | 17.33K | 182.81K | 377.54K | 114.01K | 775.05K | 0 | 0 | 0 | 0 |
Effective Tax Rate % | -0.05% | -0.19% | -5.87% | 31.51% | -1.45% | -5.94% | 0% | 0% | 0% | 0% |
Net Income | -6.21M▲ 0% | -9.06M▼ 45.9% | -3.3M▲ 63.6% | 820.79K▲ 124.9% | -7.96M▼ 1070.0% | -13.83M▼ 73.7% | -18.54M▼ 34.1% | -16.18M▲ 12.7% | -19.14M▼ 18.3% | -21.13M▲ 0% |
Net Margin % | -20.69% | -24.43% | -8.31% | 1.48% | -14.16% | -27.47% | -34.74% | -29.73% | -29.33% | -30.41% |
Net Income Growth % | -933.24% | -45.91% | 63.59% | 124.88% | -1070% | -73.71% | -34.07% | 12.73% | -18.3% | -39.63% |
Net Income (Continuing) | -6.21M | -9.06M | -3.3M | 820.79K | -7.96M | -13.83M | -18.54M | -16.18M | -19.14M | -21.13M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -12.25▲ 0% | -17.02▼ 38.9% | -6.21▲ 63.5% | 1.54▲ 124.8% | -23.74▼ 1641.6% | -33.16▼ 39.7% | -2.15▲ 93.5% | -1.17▲ 45.6% | -0.63▲ 46.2% | -0.45▲ 0% |
EPS Growth % | -920.83% | -38.94% | 63.51% | 124.8% | -1641.56% | -39.68% | 93.52% | 45.58% | 46.15% | 41.99% |
EPS (Basic) | -12.25 | -17.02 | -6.21 | 1.55 | -23.74 | -33.16 | -2.15 | -1.17 | -0.63 | - |
Diluted Shares Outstanding | 511.2K | 532.26K | 530.94K | 532.31K | 656.93K | 1.93M | 11.97M | 19.15M | 30.29M | 47.09M |
Basic Shares Outstanding | 506.92K | 532.26K | 530.94K | 530.8K | 656.93K | 1.93M | 11.97M | 19.15M | 30.29M | 47.09M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
COSM Balance Sheet
Cosmos Health Inc. (COSM) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 9.51M | 18.35M | 21.18M | 40.77M | 39.83M | 56.04M | 36.61M | 25.46M | 38.39M | 36.89M |
Cash & Short-Term Investments | 782.85K | 3.58M | 277.48K | 851.19K | 297.95K | 20.76M | 3.85M | 336.25K | 761.83K | 548.93K |
Cash Only | 782.85K | 864.34K | 38.54K | 628.39K | 286.49K | 20.75M | 3.83M | 315.11K | 715.67K | 514.7K |
Short-Term Investments | 0 | 2.72M | 238.94K | 222.79K | 11.47K | 14.88K | 20.07K | 21.15K | 46.16K | 34.23K |
Accounts Receivable | 1.43M | 4.94M | 9.27M | 26.91M | 30.14M | 22.76M | 21.71M | 15.88M | 22.56M | 21.46M |
Days Sales Outstanding | 17.35 | 48.65 | 85.26 | 177.27 | 195.59 | 165.02 | 148.47 | 106.5 | 126.16 | 107.67 |
Inventory | 3.09M | 3.2M | 3.47M | 3.29M | 3.15M | 3.45M | 4.79M | 4.36M | 5.78M | 5.65M |
Days Inventory Outstanding | 40.24 | 33.71 | 35.21 | 25.38 | 23.98 | 28.38 | 35.65 | 31.72 | 36.76 | 32.57 |
Other Current Assets | 772.62K | 189.76K | 665.49K | 1.1M | -4.77K | 9.07M | 1.95M | 4.89M | 9.29M | 9.23M |
Total Non-Current Assets | 1.17M | 2.35M | 2.7M | 3.07M | 9.6M | 11.67M | 29.41M | 28.85M | 27.09M | 25.48M |
Property, Plant & Equipment | 114.57K | 1.43M | 1.73M | 1.76M | 2.93M | 2.93M | 11.62M | 10.4M | 11.78M | 10.95M |
Fixed Asset Turnover | 261.97x | 26.01x | 22.87x | 31.53x | 19.17x | 17.18x | 4.60x | 5.23x | 5.54x | 5.84x |
Goodwill | 0 | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K | 49.7K |
Intangible Assets | 41.99K | 247.07K | 213.98K | 180.81K | 436.07K | 657.22K | 7.63M | 7.71M | 7.52M | 9.24M |
Long-Term Investments | 0 | 0 | 4.38K | 0 | 0 | 0 | 165.93K | 5.77M | 0 | 0 |
Other Non-Current Assets | 1.01M | 624.48K | 698.06K | 905.32K | 5.33M | 8.03M | 9.94M | 4.92M | 7.74M | 5.23M |
Total Assets | 10.68M▲ 0% | 20.69M▲ 93.9% | 23.88M▲ 15.4% | 43.84M▲ 83.6% | 49.43M▲ 12.7% | 68.04M▲ 37.6% | 66.01M▼ 3.0% | 54.31M▼ 17.7% | 65.48M▲ 20.6% | 62.37M▲ 0% |
Asset Turnover | 2.81x | 1.79x | 1.66x | 1.26x | 1.14x | 0.74x | 0.81x | 1.00x | 1.00x | 1.07x |
Asset Growth % | 242.33% | 93.85% | 15.39% | 83.61% | 12.74% | 37.65% | -2.97% | -17.73% | 20.56% | 38.98% |
Total Current Liabilities | 13.7M | 22.27M | 28.24M | 34.29M | 29.93M | 21.75M | 24.32M | 25.76M | 38.27M | 34.08M |
Accounts Payable | 2.17M | 5.93M | 8M | 11.97M | 12.13M | 10.26M | 11.91M | 11.16M | 14.62M | 14.82M |
Days Payables Outstanding | 28.18 | 62.46 | 81.1 | 92.31 | 92.39 | 84.36 | 88.68 | 81.26 | 93.03 | 83.69 |
Short-Term Debt | 10.18M | 15.02M | 18.65M | 19.7M | 13.34M | 8.04M | 8.23M | 9.55M | 13.52M | 11.89M |
Deferred Revenue (Current) | 0 | 1.07M | 247.32K | 22.34K | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 111.21K | 165.27K | 799.73K | 1.3M | 2.7M | 3.47M | 3.35M | 7.11M | 7.37M |
Current Ratio | 0.69x | 0.82x | 0.75x | 1.19x | 1.33x | 2.58x | 1.51x | 0.99x | 1.00x | 1.08x |
Quick Ratio | 0.47x | 0.68x | 0.63x | 1.09x | 1.23x | 2.42x | 1.31x | 0.82x | 0.85x | 0.92x |
Cash Conversion Cycle | 29.42 | 19.91 | 39.37 | 110.34 | 127.18 | 109.03 | 95.45 | 56.96 | 69.88 | 56.55 |
Total Non-Current Liabilities | 0 | 1.74M | 2.1M | 13.72M | 15.12M | 6.63M | 5.65M | 4.02M | 8.78M | 8.47M |
Long-Term Debt | 0 | 1.55M | 0 | 11.27M | 12.72M | 2.86M | 3.04M | 1.56M | 5.85M | 6.12M |
Capital Lease Obligations | 0 | 0 | 435.55K | 778.71K | 844.42K | 860.1K | 850.13K | 501.8K | 373.47K | 1.72M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 183.58K | 1.66M | 1.66M | 1.55M | 2.91M | 1.76M | 1.96M | 2.56M | 1.88M |
Total Liabilities | 13.7M | 24.01M | 30.34M | 48.01M | 45.05M | 28.38M | 29.97M | 29.78M | 47.05M | 42.54M |
Total Debt | 10.18M | 16.58M | 19.29M | 32.04M | 27.12M | 12.03M | 12.42M | 11.82M | 19.97M | 18.48M |
Net Debt | 9.4M | 15.71M | 19.25M | 31.41M | 26.84M | -8.72M | 8.59M | 11.51M | 19.25M | 17.97M |
Debt / Equity | - | - | - | - | 6.19x | 0.30x | 0.34x | 0.48x | 1.08x | 0.93x |
Debt / EBITDA | - | - | 138.93x | 10.30x | - | - | - | - | - | -1.12x |
Net Debt / EBITDA | - | - | 138.65x | 10.10x | - | - | - | - | - | -1.09x |
Interest Coverage | -2.79x | -0.33x | -0.80x | 1.43x | -1.19x | -2.29x | -20.40x | -14.99x | -6.30x | -6.00x |
Total Equity | -3.03M▲ 0% | -3.32M▼ 9.6% | -6.46M▼ 94.8% | -4.16M▲ 35.6% | 4.38M▲ 205.2% | 39.66M▲ 805.5% | 36.04M▼ 9.1% | 24.53M▼ 31.9% | 18.42M▼ 24.9% | 19.83M▲ 0% |
Equity Growth % | -72.74% | -9.56% | -94.75% | 35.6% | 205.25% | 805.52% | -9.11% | -31.93% | -24.9% | -100.69% |
Book Value per Share | -5.92 | -6.23 | -12.17 | -7.82 | 6.67 | 20.57 | 3.01 | 1.28 | 0.61 | 0.42 |
Total Shareholders' Equity | -3.03M | -3.32M | -6.46M | -4.16M | 4.38M | 39.66M | 36.04M | 24.53M | 18.42M | 19.83M |
Common Stock | 12.82K | 13.88K | 13.22K | 13.48K | 702 | 10.61K | 15.98K | 23.69K | 41.15K | 49.87K |
Retained Earnings | -7.21M | -16.27M | -19.57M | -18.75M | -34.35M | -66.23M | -91.64M | -114.02M | -133.17M | -135.97M |
Treasury Stock | -95.88K | -225.49K | -411.85K | -611.85K | -816.71K | -816.71K | -917.16K | -917.16K | -917.16K | -917.16K |
Accumulated OCI | -1.39M | 32.83K | -16.34K | 854.9K | -151.62K | -1.13M | -419.84K | -2.13M | 331.5K | 36.44K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COSM Cash Flow Statement
Cosmos Health Inc. (COSM) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -8.76M | -1.56M | -4.79M | -11.5M | -7.1M | -14.87M | -15.64M | -7.72M | -8.45M | -10.84M |
Operating CF Margin % | -29.19% | -4.19% | -12.07% | -20.76% | -12.62% | -29.54% | -29.29% | -14.18% | -12.94% | - |
Operating CF Growth % | -312.03% | 82.25% | -207.9% | -140.18% | 38.29% | -109.53% | -5.15% | 50.65% | -9.47% | -1129.34% |
Net Income | -6.21M | -9.06M | -3.3M | 820.79K | -7.96M | -13.83M | -18.54M | -16.18M | -19.14M | -21.13M |
Depreciation & Amortization | 25.9K | 43.93K | 394.63K | 397.6K | 449.69K | 188.89K | 614.38K | 1.25M | 1.37M | 1.4M |
Stock-Based Compensation | 740.59K | 242K | 0 | 0 | 5.9M | 24.4K | 577.93K | 1.69M | 2.31M | 1.72M |
Deferred Taxes | 0 | 0 | 0 | -178.43K | -714.11K | 780.1K | 656.98K | -11.84K | 22.72K | 12K |
Other Non-Cash Items | 2.84M | 6.55M | 1.73M | -667.16K | 1.52M | 6.66M | 8.96M | 5.38M | 7.77M | 7.62M |
Working Capital Changes | -6.15M | 667.35K | -3.61M | -11.87M | -6.3M | -8.69M | -7.9M | 159.68K | -777.93K | -466.71K |
Change in Receivables | -706.3K | 465.45K | -4.32M | -15.72M | -8.46M | -7.46M | -4.03M | 1.23M | -6.11M | -5.02M |
Change in Inventory | -2.62M | 1.43M | -271.45K | 393.15K | -89.58K | -485.47K | -890.9K | 146.45K | -829.98K | -615.49K |
Change in Payables | 809.12K | -629.72K | 2.73M | 3.21M | 3.82M | 1.73M | 716.62K | 1.05M | 4.47M | 3.76M |
Cash from Investing | -14.48K | -195.77K | 588.93K | -117.74K | -826.82K | -21.5K | -13.76M | -798.27K | -2.01M | -2.72M |
Capital Expenditures | -55.34K | -503.36K | -672.79K | -117.74K | -581.4K | -74.21K | -2.98M | -418.07K | -55.67K | -54.23K |
CapEx % of Revenue | 0.18% | 1.36% | 1.7% | 0.21% | 1.03% | 0.15% | 5.58% | 0.77% | 0.09% | 0.08% |
Acquisitions | 40.86K | 307.59K | 0 | 0 | 0 | 0 | -5.23M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | -245.42K | 55.34K | -5.55M | -380.19K | -1.96M | -1.66M |
Cash from Financing | 9.29M | 1.99M | 3.59M | 12.46M | 7.27M | 35.05M | 12.69M | 5.05M | 14.06M | 15.36M |
Debt Issued (Net) | 9.23M | 2.07M | 4.43M | 12.66M | 7.39M | -13.86M | -21.41K | 548.24K | 10.47M | 8.48M |
Equity Issued (Net) | 57.32K | -80.05K | -845.25K | -200K | -126.86K | 41.28M | 9.9M | 649.04K | 5.42M | 7.25M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.2M | 0 | 0 |
Share Repurchases | -34.46K | -80.05K | -845.25K | -200K | -376.86K | 0 | -100.45K | 0 | 0 | 0 |
Other Financing | 0 | 0 | 0 | 0 | 0 | 7.63M | 2.82M | 10.04M | -1.83M | -369.29K |
Net Change in Cash | 66.26K▲ 0% | 81.49K▲ 23.0% | -825.81K▼ 1113.4% | 589.86K▲ 171.4% | -341.91K▼ 158.0% | 20.46M▲ 6085.0% | -16.92M▼ 182.7% | -3.52M▲ 79.2% | 3.14M▲ 189.4% | 1.42M▲ 0% |
Free Cash Flow | -8.82M▲ 0% | -2.06M▲ 76.6% | -5.46M▼ 165.3% | -11.62M▼ 112.7% | -7.99M▲ 31.3% | -15.25M▼ 91.0% | -24.8M▼ 62.6% | -8.14M▲ 67.2% | -8.5M▼ 4.5% | -11.09M▲ 0% |
FCF Margin % | -29.37% | -5.55% | -13.77% | -20.97% | -14.2% | -30.3% | -46.47% | -14.95% | -13.03% | -15.96% |
FCF Growth % | -312.15% | 76.65% | -165.3% | -112.75% | 31.26% | -90.97% | -62.61% | 67.2% | -4.53% | -94.94% |
FCF per Share | -17.24 | -3.87 | -10.29 | -21.83 | -12.16 | -7.91 | -2.07 | -0.42 | -0.28 | -0.24 |
FCF Conversion (FCF/Net Income) | 1.41x | 0.17x | 1.45x | -14.01x | 0.89x | 1.08x | 0.84x | 0.48x | 0.44x | 0.52x |
Interest Paid | 0 | 0 | 447.73K | 955.38K | 2.06M | 588.05K | 406.88K | 0 | 0 | 275.43K |
Taxes Paid | 0 | 0 | 11.61K | 14.13K | 0 | 0 | 0 | 0 | 0 | 0 |
COSM Key Ratios
Cosmos Health Inc. (COSM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | - | -7289.22% | -62.81% | -48.99% | -53.43% | -89.13% | -96.48% |
Return on Invested Capital (ROIC) | -102.97% | -9.82% | -1.52% | 10.17% | -11.63% | -18.04% | -43.34% | -28.9% | -33.66% | -33.54% |
Gross Margin | 6.52% | 6.5% | 9.23% | 14.55% | 14.81% | 11.83% | 8.15% | 7.92% | 12.1% | 10.4% |
Net Margin | -20.69% | -24.43% | -8.31% | 1.48% | -14.16% | -27.47% | -34.74% | -29.73% | -29.33% | -30.41% |
Debt / Equity | - | - | - | - | 6.19x | 0.30x | 0.34x | 0.48x | 1.08x | 0.93x |
Interest Coverage | -2.79x | -0.33x | -0.80x | 1.43x | -1.19x | -2.29x | -20.40x | -14.99x | -6.30x | -6.00x |
FCF Conversion | 1.41x | 0.17x | 1.45x | -14.01x | 0.89x | 1.08x | 0.84x | 0.48x | 0.44x | 0.52x |
Revenue Growth | 344.28% | 23.56% | 6.99% | 39.65% | 1.5% | -10.48% | 6.02% | 1.97% | 19.93% | 29.75% |
Related:COSM Dividend History·COSM Revenue History·COSM Price History·COSM P/E History·COSM Financial Ratios·COSM Institutional Holders
COSM SEC Filings & Documents
Cosmos Health Inc. (COSM) SEC filings — annual & quarterly reports (10-K, 10-Q)
COSM Frequently Asked Questions
Cosmos Health Inc. (COSM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cosmos Health Inc. (COSM) reported $69.5M in revenue for fiscal year 2025.
Cosmos Health Inc. (COSM) grew revenue by 19.9% over the past year. This is strong growth.
Cosmos Health Inc. (COSM) reported a net loss of $21.1M for fiscal year 2025.
Dividend & Returns
Cosmos Health Inc. (COSM) has a return on equity (ROE) of -89.1%. Negative ROE indicates the company is unprofitable.
Cosmos Health Inc. (COSM) had negative free cash flow of $11.1M in fiscal year 2025, likely due to heavy capital investments.